allodynia glp-1 treatment Pharmacovigilance analysis of neurological adverse events associated with receptor agonists based on the FDA Adverse Event Reporting System Allodynia is an increased skin

10.1073/pnas.0902834106 235 ZhaoC.LiW.-W.FranklinR

When this system is functioning well, you might barely notice the occasional cold

Sun, B., Jia, X., Yang, F., Ren, G

The findings also support earlier evidence summarized in a Science Progress systematic review, which suggests that semaglutide and tirzepatide are the GLP-1 medicines most often linked with temporary hair shedding (2 GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling Go to source) Trusted Source GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling Go to source)